CEP104
protein-codingcentrosomal protein 104, the group of Cilia and flagella associated|TOG domain containing
Gene summary
This gene encodes a centrosomal protein required for ciliogenesis and for ciliary tip structural integrity. The mammalian protein contains three amino-terminal hydrophobic domains, two glycosylation sites, four cysteine-rich motifs, and two regions with homology to the glutamate receptor ionotropic, NMDA 1 protein. During ciliogenesis, the encoded protein translocates from the distal tips of the centrioles to the tip of the elongating cilium. Knockdown of the protein in human retinal pigment cells results in severe defects in ciliogenesis with structural deformities at the ciliary tips. Allelic variants of this gene are associated with the autosomal-recessive disorder Joubert syndrome, which is characterized by a distinctive mid-hindbrain and cerebellar malformation, oculomotor apraxia, irregular breathing, developmental delay, and ataxia. [provided by RefSeq, Feb 2016]
- KIAA0562
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~45.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014770
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0005308
Submitter: ClinGen
The *CEP104* gene is located on chromosome 1 at 1p36.32 and encodes the centrosomal protein 104kDa. The protein contains an IFT25/APC10-like domain, two coiled-coil domains, a tumor overexpressed gene domain, four zinc finger domains, and an SxIP motif. This centrosomal protein is required for ciliogenesis and for ciliary tip structural integrity. Nagase et al. (1998) screened large proteins expressed in the brain with RT-PCR analysis and detected variable expression in all human tissues examined, with highest levels in kidney and skeletal muscle. Multiple disease entities have been reported in association with this gene, including autosomal recessive Joubert syndrome and autosomal recessive intellectual developmental disorder. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there was no evidence of differences in their molecular mechanism, inheritance pattern, or phenotypic spectrum. Therefore, these disease entities have been lumped into one disease entity: autosomal recessive ciliopathy: MONDO:0005308. The *CEP104* gene was first reported in relation to autosomal recessive Joubert syndrome in 2015 (Srour et al., PMID: 26477546). Patients with *CEP104* gene variants have been reported to have a distinctive cerebellar and brain stem malformation (known as the molar tooth sign), hypotonia, and developmental delays which are the three primary features of Joubert syndrome. In addition, individuals with *CEP104* variants have also been reported to have oculomotor apraxia and intellectual disability. At least 9 variants (nonsense, frameshift, splice site) have been reported in 9 probands across 4 publications (PMIDs: 26477546, 31625690, 34196201, 35359234 included in this curation). The mechanism of pathogenicity is known to be loss of function. A maximum score of 12 pts. genetic evidence was reached, considering case-level data and segregation data. This gene-disease relationship is also supported by expression studies, functional studies, in vitro assays in non-patient cells, and animal models. The scored expression data include the detection of cloned *CEP104* (known as Glybp) in rat cortex, hippocampus, cerebellum, and brainstem tissue (Kumar et al., PMID: 7488117). In addition, another expression study noted cloned human *CEP104* (known as KIAA0562) in all human tissues examined, with highest levels in kidney and skeletal muscle (Nagase et al., PMID: 9628581). The scored functional evidence involves RNAi experiments with *CEP104*-depleted cultures of human RPE1 retinal pigment epithelial cells to demonstrate a loss of *CEP104* staining at the tip of the primary cilium and daughter centriole, significant reduction in cilia formation, and significant reduction in length of cilia which supports the hypothesis that *CEP104* is required for ciliogenesis (Satish Tammana, et al., PMID: 23970417). Frikstad et al. showed that *CEP104* silencing in zebrafish causes cilia-related manifestations, including a shortened cilia in Kupffer's vesicle, heart laterality, and cranial nerve development defects. This study also completed in vivo and in vitro analyses of *CEP104* and its interaction with another Joubert syndrome-associated cilia tip protein, CSPP1. The loss of *CEP104* or CSPP1 in human cells leads to defective Hedgehog signaling in cilia (Frikstad et al., PMID: 31412255). A total of 4.5 pts. experimental evidence was reached. In summary, there is definitive evidence supporting the relationship between *CEP104* and autosomal recessive ciliopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Kidney Cystic and Ciliopathy Disorders GCEP on the meeting date May 13th, 2024 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0014770
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014770
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0018772
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CEP104 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_014704.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 114 | 2 | 119 | ||
| missense | 1 | 206 | 45 | 1 | 253 | |
| nonsense | 4 | 15 | 1 | 20 | ||
| start loss | 0 | |||||
| frameshift | 11 | 16 | 1 | 28 | ||
| splice donor/acceptor (+/-2bp) | 2 | 12 | 10 | 1 | 2 | 27 |
| Total | 18 | 43 | 221 | 160 | 5 | 447 |
Highest pathogenic variant AF is 0.00040422552
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_055519.1 | 21 | MANE Select | |
| Ensembl | ENSP00000367476.3 | 21 | MANE Select | |
| Ensembl | ENSP00000367468.3 | 6 | Standard | |
| Ensembl | ENSP00000367468.3 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Molecular Function
- protein binding
- glycine binding
- glutamate binding
- thienylcyclohexylpiperidine binding
Cellular Component
- spindle pole
- centriole
- cilium
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378230
- Coding exons
- 21
- Length
- 45134
- Individuals with no LoFs
- 125617
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 131
- Defined
- 125748
- p
- 0.000521
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.444 | 503 | 532 | 0.946 | 0.0000312 | 6046 |
| Missense (PolyPhen) | 144 | 176.07 | 0.81784 | 2011 | ||
| Synonymous | 1.65 | 171 | 201 | 0.852 | 0.0000126 | 1737 |
| Loss of Function | 3.05 | 28 | 51.7 | 0.542 | 0.00000291 | 604 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00049 | 0.00049 | rare |
| Latino/Admixed American | 0.00027 | 0.00026 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00051 | 0.00051 | rare |
| European (Non-Finnish) | 0.00078 | 0.00078 | rare |
| South Asian | 0.00023 | 0.00023 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Required for ciliogenesis and for structural integrity at the ciliary tip. {ECO:0000269|PubMed:23970417}.;
- Disease
- DISEASE: Joubert syndrome 25 (JBTS25) [MIM:616781]: A form of Joubert syndrome, a disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy, renal disease, liver fibrosis, and polydactyly. JBTS25 clinical manifestations appear to be confined to the neurologic system. JBTS25 inheritance is autosomal recessive. {ECO:0000269|PubMed:26477546}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- RVIS EVS
- -0.15
- RVIS percentile EVS
- 42.34
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |